Table 2.
Treatment | Time | Curative effect |
---|---|---|
Albumin paclitaxel + cisplatin, 2 cycles; albumin paclitaxel, 3 cycles | October 2014 to February 2015 | SD |
Anlotinib (clinical trial) | September 2015 to June 2016 | SD |
Gemcitabine + Nedaplatin | June 2016 to August 2016 | PD |
Docetaxel + bevacizumab, 4 cycles; bevacizumab, 2 cycles | August 2016 to November 2016 | SD |
Rechallenge with crizotinib | November 2016 to December 2016 | PD |
Abbreviations: SD, stable disease; PD, progressive disease.